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Abstract: To date, little is known about the long-term trajectory of generalized anxiety disorder
(GAD) symptoms in health professions (HP) students over the course of the pandemic. Like health
professionals in general, HP students may have a significantly greater susceptibility to GAD symp-
toms due to their involvement in the health care system and the associated specific stressors and
risks during the COVID-19 pandemic. The HEalth in Students during the Corona pandemic study
(HES-C) provided the opportunity to investigate the long-term course of GAD symptoms with
eight measurement points over 14 months in 9380 HP and non-HP students in Switzerland between
March 2020 and June 2021. We employed logistic regression models with clustered sandwich stan-
dard errors to estimate unadjusted and adjusted prevalence of GAD symptoms. In the full model,
we adjusted for age, gender, nationality, social status, social support, self-efficacy, and COVID-19
symptoms in the past 4 weeks. At baseline, the estimated adjusted GAD symptom prevalence
was 17.6% (95% CI = 14.4–20.7) in HP students and 24.4% (95% CI = 22.3–26.5) in their peers. With
the peak of the second SARS-CoV-2 infection wave in October/November 2020, GAD symptom
prevalence substantially increased and then remained stable over time, despite changes in the epi-
demiological situation and its associated containment measures. At the last follow-up in June 2021,
GAD symptom prevalence in HP and non-HP students was 22.9% (95% CI = 16.3–29.5) and 36.9%
(95% CI = 32.9–40.9), respectively. Absolute differences in GAD symptom prevalence between stu-
dent groups over all eight measurement points ranged from 6.2% to 14.9% (all p < 0.05). Non-HP
students are identified as a specifically vulnerable group. Accordingly, target group-specific public
health campaigns and interventions should be developed with the aim to strengthen their resources,
reducing GAD symptoms, and preventing chronification.
Keywords: generalized anxiety disorder; health professions; students; COVID-19; mental health;
young adults
1. Introduction
The rapid and global spread of SARS-CoV-2 infections since the early 2020s has posed
fundamental, existential challenges to governments, scientists, and the public. In their ef-
forts to contain the spread of the virus, governments have drastically restricted civil liberties,
imposing measures, such as curfews, quarantines, assembly bans, and mandatory home
offices. Since the first wave of SARS-CoV-2 infection reached Switzerland in March/April
2020, the country has been hit by a second and third wave in September/October 2020
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and February/March 2021, and there are strong indications that Switzerland might be
faced with a fourth wave in September/October 2021. Overall, people have been con-
fronted over a long period with constantly changing epidemiological threats, restrictions,
and unpredictability. Stressful events represent important risk factors for the emergence
of anxiety symptoms and difficulties in regulating negative emotions [1–3]. Moreover,
feelings of loneliness, intolerance of uncertainty, worry, and fear generalization are related
to symptoms of anxiety [4–7].
The consequences of containment measures, such as social isolation, boredom, and fi-
nancial problems, have considerably increased mental distress in adults in comparable
situations [8,9]. Jeong and colleagues found increased levels of psychological distress,
e.g., anxiety and anger, during isolation for Middle East respiratory syndrome [10] and
similar findings have been reported during the outbreak of novel swine-origin influenza
A [11]. Moreover, anxiety levels closely mirrored the daily number of new cases during
the 2003 outbreak of severe acute respiratory syndrome in Hong Kong [12]. Recent studies
showed that substantial proportions of the general population reported moderate-to-severe
symptoms of anxiety during the initial outbreak of COVID-19 in Iran (28%) [13], China
(29%) [14], the United Kingdom (24%) [15], Canada (20%) [16], Belgium (15%) [16], Switzer-
land (12%) [16], the Philippines (23%) [16], and Bangladesh (37%) [17]. The percentages
of moderate-to-severe anxiety in China and the UK were lower before the COVID-19 pan-
demic [18,19]. A substantially lower prevalence of anxiety symptoms before the pandemic
as compared to the pandemic has also been reported for the United States of America
(17.9%) [20] and the German adult population (44.9%) [21]. Hetkamp and colleagues found
that six weeks after the lockdown, anxiety levels in the general population of Germany
remained elevated [22]. However, in the United Kingdom and Switzerland, a decrease in
anxiety levels has been observed in the general population 20 weeks after the lockdown [15]
and in university students near the end of the first infection wave after 6 weeks [23], sug-
gesting a habituation to the threatening situation. In contrast, Généreux et al. found
that the prevalence of anxiety symptoms in the Swiss adult population remained stable
between May and November 2020 [24]. Furthermore, several recent studies raise concerns
for the mental health of younger people [24–29], particularly university students [30–33],
who appear to be more vulnerable to depression and anxiety symptoms. Similarly, health-
care workers [25,27,34–39] were at high risk of mental illness. A recent systematic review
and meta-analysis on generalized anxiety disorder among health care workers during
the pandemic found that the prevalence for this specific occupational group was 32.0%
and identified anxiety disorders as one of the fundamental psychological problems [40].
However, evidence seems to be mixed. The prevalence of anxiety disorder symptoms
was 14.9% in a national sample of internal medicine physicians in the United States of
America [41], i.e., much lower than reported in previous systematic reviews [35].
To date, little is known about the long-term trajectory of generalized anxiety disorder
(GAD) symptoms in health professions (HP) students over the course of the pandemic. Like
health professionals in general, HP students may have a significantly greater susceptibility
to GAD symptoms due to their involvement in the health care system and the associated
specific stressors and risks during the COVID-19 pandemic. Moreover, the existing evi-
dence among the few studies that assessed changes in anxiety levels in the course of the
pandemic is mixed, relate only to changes over a few weeks or months, and the majority are
available only for the general adult population. In the present study, we therefore aimed to
(1) examine the course of GAD symptoms in HP and non-HP students over 14 months of
the COVID-19 pandemic, (2) to compare levels of GAD symptoms among HP students and
their peers, and (3) to identify factors associated with GAD symptoms. Monitoring and
understanding different levels of GAD symptom susceptibility and its associated factors in
students is critical for differentiated evidence-based public health interventions that are
appropriate for the target group. The HEalth in Students during the Corona pandemic
(HES-C) study provided the opportunity to study the long-term course of GAD symptoms
with eight measurement points over 14 months in this under-investigated population.
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2. Materials and Methods
2.1. Survey Design and Study Design
Study data stem from the HES-C study, which aims to (1) evaluate the health of
students during the pandemic, (2) investigate changes in health behavior and associated
factors, as well as (3) assess students’ perception of the pandemic and related measures and
their impact on students’ lives. All enrolled students at the Zurich University of Applied
Sciences (ZHAW) (N = 13,500) were invited to participate in nine consecutive surveys that
were administered between April 2020 and June 2021 in an open cohort design. Open
cohort studies allow subjects to enter and exit the study population throughout the entire
study, thus better reflecting the realities of universities. Each survey lasted about 20–25 min
and ran for a total period of seven working days. Participants’ informed consent was
obtained before each survey. Methods and questionnaire construction have been published
in detail by Dratva and colleagues [42]. In the present study, we used the pooled data from
eight of the nine survey waves (N = 9380). Data collection of the included waves took place
from 3 April 2020–14 April 2020, 30 April 2020–11 May 2020, 5 October 2020–13 October
2020, 30 November 2020–10 December 2020, 21 January 2020–29 January 2021, 8 March 2021–
16 March 2021, 3 May 2021–11 May 2021, and 14 June 2021–23 June 2021. The measurement
time points covered different epidemiologic situations and governmental constraints to
contain the pandemic (Figure 1). The study was approved by both the local cantonal ethics
committee (BASEC-Nr. Req-2020-00366) and the ZHAW data protection officer.
Figure 1. HES-C measurement points and the course of the COVID-19 pandemic in Switzerland.
Legend: Vertical dashed lines indicate the start of each survey wave, with red lines referring to
those included in the present study; 7-day confirmed cases and death per 100,000 population
are daily moving averages over 7 days. The KOF (Konjunkturforschungsstelle) Stringency Index
Plus is an adopted version of the Oxford Stringency Index, which allows assessment of national
and cantonal measures. The index ranges from 0 (=no governmental containment measures) to
100 (=full lockdown).
2.2. Measures
2.2.1. Outcome: Generalized Anxiety Disorder Symptoms
We assessed generalized anxiety disorder symptoms using the Generalized Anxiety
Disorder scale (GAD-7) [43], which measures self-reported anxiety levels of participants in
Int. J. Environ. Res. Public Health 2021, 18, 10833 4 of 14
the past 2 weeks. The GAD-7 includes seven items to be rated on a 4-point Likert scale,
ranging from 0 (not at all) to 3 (ever day). Items are summed, resulting in a total score
ranging from 0 to 21, with higher scores indicating higher levels of anxiety. Based on the
total score, 4 levels of anxiety severity were derived: minimal (0–4), mild (5–9), moderate
(10–14), and severe (5–21) [43]. As a screening instrument for GAD symptoms, a GAD-7
score of 10 or greater has been proposed, yielding a sensitivity of 89% and a specificity
of 82% for GAD [43]. We used the latter threshold score to classify students as having
generalized anxiety disorder symptoms (0 = no, 1 = yes).
2.2.2. Predictor and Covariates
For our primary predictor, participating students were classified into those studying
in the Department of Health Professions and those studying in other departments (0 = non-
health professions students, 1 = health professions students). Non-health professions
students included students from the following faculties: Applied Linguistics, Applied
Psychology, Architecture, Design and Civil Engineering, Life Science, Facility Management,
School of Engineering, School of Management and Law, and Social Work.
Sociodemographic covariates included gender (0 = women, 1 = men), age at last
birthday in complete years centered at the mean value, nationality (0 = Swiss, 1 = foreign),
and mean-centered social status of parents at student age 16 using a modified McArthur
scale ranging from 1 (lowest) to 10 (highest) [44].
Psychosocial covariates included mean-centered self-efficacy and social support.
We used the Allgemeine Selbstwirksamkeit Kurzskala (ASKU; General Self-Efficacy Short
Scale) [45] to assess self-efficacy. The ASKU comprises three items (“In difficult situations,
I can rely on my abilities”, “I can cope with most problems on my own”, and “Generally,
I can handle strenuous and complicated tasks well”) and participants were asked to re-
spond on a five-point Likert scale (from 1 = “strongly disagree” to 5 = “strongly agree”).
The ASKU scale scores range ranges from 1 to 5 and represents the mean score over all
three items, with higher scores indicating higher self-efficacy. Social support was assessed
using the Oslo Social Support Scale (OSSS-3) [46]. The OSSS-3 explores social support
through three items about the number of close confidants, sense of concern or interest from
other people, and relationship to neighbors. We used the established cut-off values of the
OSSS-3 sum scores [46] to classify respondents into individuals with strong (0 = 12–14),
poor (1 = 3–8), and moderate (2 = 9–11) social support.
COVID-19-related symptoms were assessed using the following statement with binary
response option (0 = no, 1 = yes): “Have you had symptoms in the past 4 weeks that would
be compatible with a COVID-19 infection? For example, cough (usually dry), sore throat,
shortness of breath, and fever, muscle pain”.
In order to capture time trends, covariates for time (0 = baseline measurement at
M1, 1 = [M2, M3, . . . M8], and interactions between the latter and our primary predictor
were used.
2.3. Statistical Analyses
Descriptive statistics (i.e., frequencies, percent, mean, and standard deviation) were
applied to evaluate the characteristics of the samples. We used one-way ANOVA and Chi-
square-tests to assess mean-level stability between measurement points. Logistic regression
models with a clustered sandwich estimator for standard errors, which adjust for repeated
measures of the same subject, were used to estimate adjusted generalized anxiety disorder
symptoms, i.e., the conditional probability of generalized anxiety disorder symptoms given




∣∣xj) = exp(xjβ)1 + exp(xjβ) (1)
where xj refers to the model predictors 1 through j and β refers to the respective unknown
parameter to be estimated.
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Models were gradually adjusted. Starting with a restricted model (Model 1) with
only the primary predictor and time variables, subsequent models introduced additional
covariates for demographics (Model 2: age, gender), social origin (Model 3: parents’ social
status, nationality), and psychosocial covariates (Model 4: self-efficacy, social support,
COVID-19 symptoms). The purpose of this procedure was to evaluate the stability of the
primary predictor over the course of the pandemic, since not all covariates were recorded
at all measurement time points. For Models 1 and 2, all involved variables were available at
all time points (M1–M8). Model 3 comprised 5 measurement time points (M1, M3, M6–M8),
and Model 4 comprised 4 measurement time points (M1, M3, M6, M8). For all logistic
models, we visually checked whether independent variables were related linearly to the log
odds, checked an adequate minimum of 10 cases with the least frequent outcome for each
independent variable, and assessed multicollinearity using the variance inflation factor
(VIF) in the multivariable models. Underlying assumptions of the logistic models were met
in all models. We report odds ratios (ORs) with corresponding 95% confidence intervals
(95% CIs), predictive margins (average predicted probability), and average marginal effects.
Statistical significance was established at p < 0.05. We used Stata Version 15.1 (StataCorp,
College Station, TX, USA) for statistical analyses.
3. Results
3.1. Participants’ Characteristics
Over all eight included survey waves, 9380 students participated in the study, and 70.6%
were women and 29.4% were men (Table 1). Mean age was 25.8 years, and 91.7% were
Swiss nationals. The percentage of health professional students was 23.8%, which is con-
siderably higher than their share in the total student population (13.0%). Mean parents’
social status was 5.6, which is almost exactly the middle of the scale and means that most
students located themselves in the social middle class.
With respect to psychosocial covariates, overall mean self-efficacy was high (3.8),
and most students could count on at least medium (59.7%) or even high (22.5%) social
support. However, 17.8% of students reported low social support. Finally, 16.4% of the
students said that they experienced COVID-19 symptoms in the past 4 weeks before
the survey.
With the exception of parents’ social status, all statistical tests for mean-level stability
between measurements indicated statistically significant differences. However, due to
the large number of observations and the associated statistical power, this should not be
overestimated. In particular, a look at the range shows that the values do not vary strongly
between the surveys. For example, the proportion of health professions students ranges
from 20.8% to 30.7%, the proportion of women ranges from 68.6% to 74.9%, and self-efficacy
ranges from 3.7–3.8 with standard deviations between 0.6 and 0.7.
Table 1. Participant characteristics.
Measurement
Variable M1 M2 M3 M4 M5 M6 M7 M8 Total p
Faculty (%) <0.001
HP students 24.5 23.9 20.8 22.6 22.7 30.7 24.4 22.4 23.8
Non-HP
students 75.5 76.1 79.2 77.4 77.3 69.3 75.6 77.6 76.2
Gender (%) <0.05
Women 69.8 70.0 69.0 71.9 68.6 74.9 72.9 71.9 70.6
Men 30.2 30.0 31.0 28.1 31.4 25.1 27.2 28.1 29.4




5.6 ± 1.6 5.6 ± 1.7 5.6 ± 1.7 5.7 ± 1.6 5.7 ± 1.7 5.7 ± 1.7 0.878
Nationality
(%) <0.05
Foreign 8.7 10.6 6.4 7.7 6.8 8.3
Swiss 91.3 89.4 93.6 92.3 93.2 91.7
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Table 1. Cont.
Measurement
Variable M1 M2 M3 M4 M5 M6 M7 M8 Total p
Self-efficacy
(m ± sd) 3.8 ± 0.6 3.8 ± 0.6 3.7 ± 0.7 3.8 ± 0.6 3.8 ± 0.6 <0.001
Social support
(%) <0.001
Low (3–8) 15.3 19.5 21.9 19.4 17.8
Medium
(9–11) 60.0 60.0 59.0 58.6 59.7
High (12–14) 24.7 20.5 19.1 22.0 22.5
COVID-19
symptoms (%) <0.001
No 78.6 86.0 86.3 93.1 83.6
Yes 21.4 14.0 13.7 6.9 16.4
Number of
observations 2170 1376 1079 1095 1376 700 926 658 9380
p = probability (Pearson Chi-squared test for categorical variables; one-way ANOVA for continuous variables); m ± sd = mean ± standard
deviation; HP = health professionals; Mx = measurement point.
3.2. Generalized Anxiety Disorder Symptoms: Trajectory, Risk, and Protective Factors
Table 2 shows the GAD-7 scores and generalized anxiety disorder levels according
to the established threshold scores [47]. Across all waves, the mean GAD-7 score was
7.0, and the proportion of students with moderate and severe anxiety scores amounted to
17.4% and 9.0%, respectively. Hence, the crude prevalence of generalized anxiety disorder
symptoms was 26.4%. With respect to mean-level stability, GAD-7 scores, the proportion
of participants in GAD-7 categories, and the proportion of students with GAD symptoms
varied substantially between survey waves (all with p < 0.001). From baseline measurement
(M1) to the first follow-up (M2), the prevalence of anxiety symptoms first declined, then
increased substantially at the third (M2- > M3) and fourth (M3- > M4) follow-up, and
remained thereafter in a range between 30.7% and 33.8%.
Table 2. Generalized anxiety disorder scores and levels over time.
Measurement
Variable M1 M2 M3 M4 M5 M6 M7 M8 Total p
GAD-7 score
(m ± sd) 6.5 ± 4.4 5.6 ± 4.3 6.8 ± 4.5 7.6 ± 4.9 8.0 ± 5.0 7.8 ± 5.0 7.4 ± 5.1 8.0 ± 5.2 7.0 ± 4.8 <0.001
GAD-7
categories (%) <0.001
Minimal (0–4) 38.7 48.3 35.5 31.5 27.2 31.6 33.6 30.3 35.6
Mild (5–9) 38.5 36.8 41.4 37.7 39.0 37.1 35.8 36.2 38.0
Moderate
(10–14) 16.4 9.6 16.2 19.7 22.4 18.9 19.4 20.1 17.4




score ≥ 10 22.8 14.9 23.1 30.8 33.8 31.3 30.7 33.6 26.4
p = probability (Pearson Chi-squared test for categorical variables; one-way ANOVA for continuous variables); m ± sd = mean ± standard
deviation; GAD = Generalized Anxiety Disorder; Mx = measurement point.
In a first restricted model (Table 3, Model 1), we estimated the effect of our primary
predictor (faculty) and included contrasts for time (measurement points) and their inter-
action with faculty. The main effect of faculty (OR = 0.64; 95% CI = 0.50–0.82) indicated
that health profession (HP) students as compared to those enrolled at other faculties were
less likely to have GAD symptoms. Furthermore, the time contrasts revealed that non-HP
students were significantly less likely to report GAD symptoms at the first follow-up at M2
(OR = 0.53; 95% CI = 0.52–0.75) as compared to their baseline GAD, were equally likely
to report GAD symptoms at the second follow-up M3 as compared to their baseline GAD
(p = 0.541), and from the fourth follow-up (M4) on, non-HP students were always substan-
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tially more likely to report GAD symptoms as compared to baseline. Interaction terms
between time and faculty were statistically not significant, indicating that HP students
share the same trajectory of GAD symptoms over time that we found for non-HP students,
i.e., HP students also experienced a decrease in GAD symptoms at the first follow-up
at M2 as compared to their baseline GAD, and from the fourth follow-up (M4) on were
always more likely to report GAD symptoms as compared to baseline. Further adjusting for
gender and age (Table 3, Model 2), parents’ social status and nationality (Table 3, Model 3),
self-efficacy, social support, and COVID-19 symptoms (Table 3, model 4), we consistently
found HP students as compared to their peers were less likely to report GAD symptoms
(Model 2: OR = 0.57; 95% CI = 0.44–0.73; Model 3: OR = 0.59; 95% CI = 0.45–0.77; Model 4:
OR = 0.67; 95% CI = 0.50–0.89). Similarly, time contrasts and interaction terms showed
the same pattern as described for Model 1 above. With respect to the covariates, men as
compared to women were less likely to report GAD symptoms. In the full model (Model 4,
adjusting for all covariates), the corresponding OR was 0.70 (95% CI = 0.58–0.85). Older
age was negatively associated with GAD symptoms in Models 2 and 3 but was no longer
statistically significant in the full model. Furthermore, students from higher social sta-
tus families were consistently less likely to report GAD symptoms (Model 4: OR = 0.93;
95% CI = 0.88–0.98) and nationality was consistently not significantly associated with GAD
symptoms. With regard to psychosocial covariates, students with high self-efficacy were
less likely (OR = 0.33; 95% CI = 0.29–0.37) and students with low social support as com-
pared to those with high social support (OR = 2.36; 95% CI = 1.82–3.05) were more likely
to report GAD symptoms. Finally, students who experienced COVID-19 symptoms in the
past four weeks before the survey were more likely to report GAD symptoms (OR = 1.44,
95% CI = 1.17–1.77).
Figure 2 shows the trajectory of the estimated absolute GAD symptoms prevalence
for HP students and their peers as well as the respective absolute difference over time,
based on the restricted model (panel A, C) and the full model (panel B, D). In the restricted
model, the estimated adjusted probabilities of reporting GAD symptoms at baseline, i.e.,
the proportion of students reporting symptoms, was 17.3% (95% CI = 14.1–20.5) for HP
students and 24.5% (95% CI = 22.4–26.6) for non-HP students. At the first follow-up (M2),
the prevalence of GAD symptoms had declined for both student groups (HP students:
8.8%; 95% CI = 5.7–11.8; non-HP students: 16.9%; 95% CI = 14.6–19.2). However, at the
second follow-up (M3), GAD prevalence had increased to baseline levels again (HP stu-
dents: 18.4%; 95% CI = 13.3–23.5; non-HP students: 24.1%; 95% CI = 21.3–27.0) and further
increased between the second and third follow-up (HP students: 24.1%; 95% CI = 18.8–29.4;
non-HP students: 32.7%; 95% CI = 29.5–35.8). Thereafter, GAD symptoms prevalence
remained at the high level of the third follow-up. At the last follow-up, the estimated
prevalence for HP students was 22.8% (95% CI = 16.1–29.6) and 36.6% (95% CI = 32.4–40.1)
for non-HP students. Absolute differences in GAD symptoms prevalence ranged from
5.8% to 13.8%, with substantially lower prevalence in HP students. With the exception
of the third and sixth measurement, where differences were only borderline significant
(M3: p = 0.053, M6: p = 0.090), differences were all significant at p < 0.01. The full model
yielded similar results. At baseline, the estimated GAD symptoms prevalence was 17.6%
(95% CI = 14.4–20.7) in HP students and 24.4% (95% CI = 22.3–26.5) in their peers. At the
last follow-up, prevalence had increased for both HP and non-HP students, and was 22.9%
(95% CI = 16.3–29.5) and 36.9% (95% CI = 32.9–40.9), respectively. Absolute differences in
GAD symptoms prevalence between student groups ranged from 6.2% to 14.9% and were
all statistically significant.
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Table 3. Logistic regression models: generalized anxiety disorder symptoms and its associations.
Variable Model 1 Model 2 Model 3 Model 4
OR p 95% CI OR p 95% CI OR p 95% CI OR p 95% CI
HP (Ref = non-HP) 0.64 0.001 0.50, 0.82 0.57 0.000 0.44, 0.73 0.59 0.000 0.45, 0.77 0.67 0.006 0.50, 0.89
Time (Ref = 1)
2 0.63 0.000 0.52, 0.75 0.63 0.000 0.52, 0.75
3 0.98 0.828 0.81, 1.19 0.94 0.541 0.78, 1.14 1.00 0.984 0.80, 1.24 1.01 0.922 0.80, 1.27
4 1.49 0.000 1.24, 1.79 1.45 0.000 1.21, 1.74
5 1.80 0.000 1.52, 2.13 1.77 0.000 1.50, 2.09
6 1.51 0.000 1.21, 1.88 1.47 0.001 1.17, 1.83 1.44 0.002 1.14, 1.82 1.35 0.023 1.04, 1.74
7 1.51 0.000 1.24, 1.83 1.46 0.000 1.20, 1.78 1.50 0.000 1.23, 1.83
8 1.78 0.000 1.44, 2.20 1.73 0.000 1.40, 2.14 1.80 0.000 1.44, 2.24 1.96 0.000 1.54, 2.50
Time × HP
(Ref = 1 × HP)
2 × HP 0.74 0.166 0.48, 1.13 0.74 0.172 0.48, 1.14
3 × HP 1.10 0.673 0.70, 1.73 1.14 0.582 0.72, 1.78 1.02 0.945 0.62, 1.68 0.94 0.809 0.57, 1.55
4 × HP 1.02 0.928 0.68, 1.53 1.03 0.870 0.69, 1.56
5 × HP 0.81 0.281 0.56, 1.19 0.83 0.331 0.57, 1.21
6 × HP 1.15 0.537 0.74, 1.78 1.15 0.526 0.74, 1.79 1.08 0.748 0.68,1.72 0.98 0.919 0.60, 1.59
7 × HP 0.99 0.957 0.64, 1.52 1.01 0.981 0.65, 1.54 0.96 0.845 0.62,1.49
8 × HP 0.80 0.363 0.49, 1.30 0.81 0.403 0.50, 1.33 0.79 0.350 0.47, 1.30 0.71 0.208 0.41, 1.21
Men (Ref = women) 0.74 0.000 0.66, 0.84 0.74 0.000 0.63, 0.86 0.70 0.000 0.58, 0.85
Age 0.98 0.001 0.97, 0.99 0.98 0.004 0.97, 0.99 1.01 0.432 0.99, 1.02
Parents’ social status 0.89 0.000 0.85, 0.93 0.93 0.004 0.88, 0.98
Foreign nationality
(Ref = Swiss) 1.19 0.156 0.94, 1.50 1.19 0.216 0.90, 1.57
Self-efficacy 0.33 0.000 0.29, 0.37
Social support (Ref = high)
Low (3–8) 2.36 0.000 1.82, 3.05
Moderate (9–11) 1.15 0.197 0.93, 1.41
COVID-19 symptoms (Ref = no) 1.44 0.000 1.17, 1.77
Constant 0.33 0.000 0.29, 0.36 0.37 0.000 0.33, 0.42 0.35 0.000 0.31, 0.41 0.23 0.000 0.19, 0.29
Number of observations 9330 9329 4936 4022
Number of subjects 6975 6974 4491 3891
Pseudo R-squared (%) 2.6 3.0 2.5 12.20
Logistic regression models with clustered sandwich estimator for standard errors; OR = Odds Ratio; p = probability; 95% CI = 95% confidence
interval; HP = health professions students; Ref = reference category; generalized anxiety disorder symptoms refer to a GAD-7 score ≥ 10.
Figure 2. Predicted probability and conditional marginal effects of HP and non-HP faculty
membership over time. Legend: Predicted adjusted probability of GAD symptoms for HP students and
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non-HP students in the restricted model (Model 1, panel (A)) and the full model (Model 4, panel
(B)), covariates fixed at means. Panels (C) (restricted model) and (D) (full model) show respective
differences in the probability of reporting GAD symptoms between HP students and non-HP students.
Dots represent point estimates; whiskers represent corresponding 95% confidence intervals.
4. Discussion
The crude prevalence of GAD symptoms in our student population in the March to
September 2020 time frame (M1-M3) was very similar to that of the adult population in
Switzerland, which was 22.3% [24]. After October 2020, the prevalence of GAD symptoms
in the student population was substantially higher and remained high, ranging from 30.7%
to 33.8% (M4-M8). While the change in GAD symptoms between April and November 2020
may well be associated with changes in the epidemiological situation, GAD symptoms
prevalence remained at a level roughly equivalent to the peak of the second wave (M4),
despite significantly lower numbers of new SARS-CoV-2 infections and related deaths
in the following months. These findings are partly in line with previous studies that
found that the evolution of the epidemiological situation, i.e., mortality and death rates,
did not seem to influence GAD symptoms [24]. However, in our student population, this
was only the case between January and June 2021, while between March and November
2020, we first observed a short-term decrease in GAD symptoms during the first infection
wave, similar to a study in the United Kingdom [15], and subsequently an increase in
GAD symptom prevalence that seemed to closely mirror the epidemiological situation.
The missing coherent association between GAD symptoms and the latter, however, lends
little support for the hypothesis suggesting a habituation to the threatening situation [23].
Moreover, unlike the GAD symptoms in the general adult population in Switzerland, which
were stable between May and November 2020 [24], our student population experienced a
substantial increase. These findings suggest that students were more susceptible to GAD
symptoms as compared to the general population, which corresponds with previous study
findings [30–33], and that their vulnerability increased over the course of the pandemic.
It might be that students’ continued uncertainty about the course of the pandemic cumu-
lated with uncertainty about continuing and completing their studies, leading to increased
anxiety symptoms. In addition, students may have been more isolated and challenged by
the rapid change to online distance learning than adults in the general population who
performed their normal work in the home office [48,49]. Furthermore, previous findings
indicated that symptoms of anxiety increased in students who were more concerned about
their own health [23]. Consequently, the observed increased levels of GAD symptom
prevalence over the course of the pandemic in our student population may be related to
increased health concerns as well.
While both HP and non-HP students experienced increases in GAD symptom preva-
lence, the difference with respect to the general adult population in Switzerland was almost
entirely due to non-HP students. Their crude GAD symptom prevalence was 32.6–37.0%
while HP students were at a level comparable to the general population at 22.8–26.6%.
The substantial higher GAD symptom prevalence of non-HP students as compared to
the general population can most likely be attributed to their significantly lower average
age. Previous studies found that younger age was associated with a higher risk of mental
illness [24–27,29]. Similarly, age was negatively associated with GAD symptoms in our
restricted models. This raises the question of why, despite their similar ages, HP students
exhibit significantly fewer GAD symptoms than their peers, and exhibit fewer GAD symp-
toms than might have been expected based on their age alone. Several factors may have
contributed to this. HP students are generally likely to have better health literacy than
non-HP students in general and mental health literacy in particular [50]. This includes
knowledge about sources of reliable health information but also the ability to better clas-
sify and understand this information based on their prior professional knowledge [51,52].
In addition, because of their involvement in the health care system, HP students often
have first-hand experience or first-hand information and have professional contacts in the
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health care system. So far, however, the presumed relationships are merely hypotheses that
should be investigated in future studies.
In all our multivariable logistic regression models, we found substantial and robust
negative associations between HP students and GAD symptoms after adjusting for age,
gender, social status, nationality, self-efficacy, social support, and COVID-19 symptoms in
the past four weeks before the survey. In the full model, adjusting for all covariates (Table 3,
Model 4), age was not associated with GAD symptoms while previous studies reported
that younger people were at a higher risk of GAD symptoms [24–27,29]. However, most of
the latter studies assessed populations with a much wider age range as compared to our
student population. Hence the lack of variation in students’ age could be the reason why
we could not detect a corresponding effect. Men as compared to women were less likely to
report GAD symptoms, a finding that is corroborated by previous studies [17,21,24,33,53].
Students’ nationality was not associated with GAD symptoms. This finding is in line with
previous studies from France [54]. However, the evidence seems to be mixed. In the United
States of America, foreign nationality has been found to be positively associated with
anxiety [55]. Moreover, we found low social status students to be more likely to report
GAD symptoms. However, evidence from previous studies seems again to be mixed: low
social status was associated with an increased likelihood to report GAD symptoms in
China [56], and a study of Chinese students in Japan found that higher social status was
associated with higher levels of anxiety [57].
With respect to psychosocial covariates, students with poor social support were more
likely and students with higher levels of self-efficacy were less likely to report GAD
symptoms, which is in line with previous French and Iranian studies assessing social
support [54] and self-efficacy [58], respectively. Our results suggest that social support and
self-efficacy are important protective factors in being able to cope with anxiety.
Finally, we found that having COVID-19 symptoms was associated with GAD symp-
toms. Previous studies reported similar results in French and Chinese university stu-
dents [33,54,57].
The findings of our study should be interpreted keeping their limitations in mind.
Firstly, we used self-reported measures to assess anxiety, which may have induced social
desirability response bias. Secondly, more women participated in the study, which could
have resulted in higher crude GAD symptom prevalence because generally women tend to
report higher GAD scores [17,21,24,33,53]. In our adjusted models, however, we adjusted
for gender. Thirdly, our student sample is not representative for young adults in general
since they belong to a more highly educated population. Whether or not higher education
proves to be a protective factor for the development of GAD symptoms is difficult to judge
because prior population-based studies have demonstrated both positive [59], negative [60],
or no educational effects [61]. Fourthly, 75–97% of students in our open cohort participated
in only one survey, depending on the model and the number of measurement time points
included in the model. Accordingly, our study has more the characteristics of a cross-
sectional study with repeated measures and accordingly no causal inferences can be drawn.
Fifthly, the different foci of the surveys and considerations of research economics meant
that not all variables were collected at all survey time points. As a result, not all model
parameters over all models could be consistently estimated using the same sample. While
for our primary predictor, i.e., HP versus non-HP students and its trajectory over time, there
were no substantial differences between the models in terms of either effect size or statistical
inference, for some covariates, such differences did occur between the models. For the latter,
in particular, it is thus not possible to conclusively determine whether these differences in
effect size or statistical inference are original or due to the specific composition of the sample.
Sixthly, previous studies found that subjects with chronic diseases, especially autoimmune
diseases, were at particular risk for mental health disorders [62,63], and that the incidence
of anxiety disorder may depend on subjects’ pre-existing health conditions rather than on
their profession [63]. Due to the lack of data on autoimmune diseases, we were unable to
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control for this possible confounder. Future studies should systematically collect data and
incorporate respective variables into their models.
5. Conclusions
The prevalence of GAD symptoms is high and has increased over time. This suggests
that there were few habituation effects to the uncertain situational dynamics during the
pandemic. HP students were significantly less affected by GAD symptoms as compared to
their non-HP student peers. For students affected by anxiety symptoms, campaigns and
interventions should be developed with the aim to strengthen their resources, and prevent
chronification. Future studies should specifically examine the link between health literacy,
access to trusted sources of information, and GAD symptoms in order to derive targeted
programs to strengthen these skills, especially in non-HP students, if necessary.
Author Contributions: Conceptualization, J.D., T.V. and A.Z.; methodology, J.D., T.V. and A.Z.;
formal analysis, T.V.; investigation, J.D., T.V. and A.Z.; data curation, T.V.; writing—original draft
preparation, T.V., and A.Z., writing—review and editing, S.A., A.v.W., T.V., A.Z. and J.D.; supervision,
J.D. and T.V.; project administration, J.D.; funding acquisition (internal funding). All authors have
read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Institutional Review Board Statement: The study was conducted according to the guidelines of
the Declaration of Helsinki and approved by both the local cantonal ethics committee (BASEC Nr.
Req-2020-00326) and the ZHAW data protection officer.
Informed Consent Statement: Informed consent was obtained from all subjects involved in the
study prior to filling in the online survey.
Data Availability Statement: The study data presented in this study are available on Zenodo data
repository (https://zenodo.org/, accessed on 14 October 2021).
Acknowledgments: We would like to thank the ZHAW students who participated in the study for
their engagement and time. The HES-C research group, consisting of Julia Dratva (PI), Thomas
Volken (Co-PI), Annina Zysset, Agnes von Wyl, Marion Huber, Simone Amendola, has dedicated
themselves to study young adult health during the pandemic.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Anyan, F.; Worsley, L.; Hjemdal, O. Anxiety symptoms mediate the relationship between exposure to stressful negative life events
and depressive symptoms: A conditional process modelling of the protective effects of resilience. Asian J. Psychiatry 2017, 29,
41–48. [CrossRef] [PubMed]
2. Ding, Y.; Xu, J.; Huang, S.; Li, P.; Lu, C.; Xie, S. Risk Perception and Depression in Public Health Crises: Evidence from the
COVID-19 Crisis in China. Int. J. Environ. Res. Public Health 2020, 17, 5728. [CrossRef] [PubMed]
3. Schneider, R.L.; Long, E.E.; Arch, J.J.; Hankin, B.L. The relationship between stressful events, emotion dysregulation, and anxiety
symptoms among youth: Longitudinal support for stress causation but not stress generation. Anxiety Stress Coping 2020, 34,
157–172. [CrossRef] [PubMed]
4. Hamm, A.O. Fear, anxiety, and their disorders from the perspective of psychophysiology. Psychophysiology 2019, 57, e13474.
[CrossRef]
5. Lauriola, M.; Carleton, R.N.; Tempesta, D.; Calanna, P.; Socci, V.; Mosca, O.; Salfi, F.; De Gennaro, L.; Ferrara, M. A Correlational
Analysis of the Relationships among Intolerance of Uncertainty, Anxiety Sensitivity, Subjective Sleep Quality, and Insomnia
Symptoms. Int. J. Environ. Res. Public Health 2019, 16, 3253. [CrossRef]
6. Stegmann, Y.; Schiele, M.; Schümann, D.; Lonsdorf, T.B.; Zwanzger, P.; Romanos, M.; Reif, A.; Domschke, K.; Deckert, J.; Gamer,
M.; et al. Individual differences in human fear generalization—Pattern identification and implications for anxiety disorders.
Transl. Psychiatry 2019, 9, 307. [CrossRef]
7. Danneel, S.; Geukens, F.; Maes, M.; Bastin, M.; Bijttebier, P.; Colpin, H.; Verschueren, K.; Goossens, L. Loneliness, Social Anxiety
Symptoms, and Depressive Symptoms in Adolescence: Longitudinal Distinctiveness and Correlated Change. J. Youth Adolesc.
2020, 49, 2246–2264. [CrossRef]
8. McLaughlin, K.A.; Conron, K.J.; Koenen, K.C.; Gilman, S.E. Childhood adversity, adult stressful life events, and risk of past-year
psychiatric disorder: A test of the stress sensitization hypothesis in a population-based sample of adults. Psychol. Med. 2009, 40,
1647–1658. [CrossRef]
Int. J. Environ. Res. Public Health 2021, 18, 10833 12 of 14
9. Skoda, E.-M.; Bäuerle, A.; Schweda, A.; Dörrie, N.; Musche, V.; Hetkamp, M.; Kohler, H.; Teufel, M.; Weismüller, B. Severely
increased generalized anxiety, but not COVID-19-related fear in individuals with mental illnesses: A population based cross-
sectional study in Germany. Int. J. Soc. Psychiatry 2020, 67, 550–558. [CrossRef]
10. Jeong, H.; Yim, H.W.; Song, Y.-J.; Ki, M.; Min, J.-A.; Cho, J.; Chae, J.-H. Mental health status of people isolated due to Middle East
Respiratory Syndrome. Epidemiol. Health 2016, 38, e2016048. [CrossRef]
11. Jones, J.H.; Salathé, M. Early Assessment of Anxiety and Behavioral Response to Novel Swine-Origin Influenza A(H1N1). PLoS
ONE 2009, 4, e8032. [CrossRef] [PubMed]
12. Leung, G.M.; Ho, L.-M.; Chan, S.K.K.; Ho, S.-Y.; Bacon-Shone, J.; Choy, R.Y.L.; Hedley, A.J.; Lam, T.H.; Fielding, R. Longitudinal
Assessment of Community Psychobehavioral Responses During and After the 2003 Outbreak of Severe Acute Respiratory
Syndrome in Hong Kong. Clin. Infect. Dis. 2005, 40, 1713–1720. [CrossRef] [PubMed]
13. Zakeri, M.A.; Rafsanjanipoor, S.M.H.; Kahnooji, M.; Heidari, F.G.; Dehghan, M. Generalized Anxiety Disorder during the
COVID-19 Outbreak in Iran. J. Nerv. Ment. Dis. 2021, 209, 491–496. [CrossRef] [PubMed]
14. Wang, C.; Pan, R.; Wan, X.; Tan, Y.; Xu, L.; McIntyre, R.S.; Choo, F.N.; Tran, B.; Ho, R.; Sharma, V.; et al. A longitudinal study on
the mental health of general population during the COVID-19 epidemic in China. Brain, Behav. Immun. 2020, 87, 40–48. [CrossRef]
[PubMed]
15. Fancourt, D.; Steptoe, A.; Bu, F. Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in
England: A longitudinal observational study. Lancet Psychiatry 2020, 8, 141–149. [CrossRef]
16. Généreux, M.; Schluter, P.J.; Hung, K.K.; Wong, C.S.; Mok, C.P.Y.; O’Sullivan, T.; David, M.D.; Carignan, M.-E.; Blouin-Genest, G.;
Champagne-Poirier, O.; et al. One Virus, Four Continents, Eight Countries: An Interdisciplinary and International Study on the
Psychosocial Impacts of the COVID-19 Pandemic among Adults. Int. J. Environ. Res. Public Health 2020, 17, 8390. [CrossRef]
17. Islam, S.; Ferdous, M.Z.; Potenza, M.N. Panic and generalized anxiety during the COVID-19 pandemic among Bangladeshi
people: An online pilot survey early in the outbreak. J. Affect. Disord. 2020, 276, 30–37. [CrossRef] [PubMed]
18. Huang, Y.; Wang, Y.; Wang, H.; Liu, Z.; Yu, X.; Yan, J.; Yu, Y.; Kou, C.; Xu, X.; Lu, J.; et al. Prevalence of mental disorders in China:
A cross-sectional epidemiological study. Lancet Psychiatry 2019, 6, 211–224. [CrossRef]
19. Giebel, C.; Corcoran, R.; Goodall, M.; Campbell, N.; Gabbay, M.; Daras, K.; Barr, B.; Wilson, T.; Kullu, C. Do people living in
disadvantaged circumstances receive different mental health treatments than those from less disadvantaged backgrounds? BMC
Public Health 2020, 20, 651. [CrossRef]
20. Cordaro, M.; Grigsby, T.J.; Howard, J.T.; Deason, R.G.; Haskard-Zolnierek, K.; Howard, K. Pandemic-Specific Factors Related to
Generalized Anxiety Disorder during the Initial COVID-19 Protocols in the United States. Issues Ment. Health Nurs. 2021, 42,
747–757. [CrossRef]
21. Bäuerle, A.; Teufel, M.; Musche, V.; Weismüller, B.; Kohler, H.; Hetkamp, M.; Dörrie, N.; Schweda, A.; Skoda, E.-M. Increased
generalized anxiety, depression and distress during the COVID-19 pandemic: A cross-sectional study in Germany. J. Public Health
2020, 42, 672–678. [CrossRef] [PubMed]
22. Hetkamp, M.; Schweda, A.; Bäuerle, A.; Weismüller, B.; Kohler, H.; Musche, V.; Dörrie, N.; Schöbel, C.; Teufel, M.; Skoda, E.-M.
Sleep disturbances, fear, and generalized anxiety during the COVID-19 shut down phase in Germany: Relation to infection rates,
deaths, and German stock index DAX. Sleep Med. 2020, 75, 350–353. [CrossRef] [PubMed]
23. Amendola, S.; von Wyl, A.; Volken, T.; Zysset, A.; Huber, M.; Dratva, J. A Longitudinal Study on Generalized Anxiety among
University Students during the First Wave of the COVID-19 Pandemic in Switzerland. Front. Psychol. 2021, 12, 643171. [CrossRef]
[PubMed]
24. Généreux, M.; Schluter, P.; Landaverde, E.; Hung, K.; Wong, C.; Mok, C.; Blouin-Genest, G.; O’Sullivan, T.; David, M.; Carignan,
M.-E.; et al. The Evolution in Anxiety and Depression with the Progression of the Pandemic in Adult Populations from Eight
Countries and Four Continents. Int. J. Environ. Res. Public Health 2021, 18, 4845. [CrossRef]
25. Huang, Y.; Zhao, N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China:
A web-based cross-sectional survey. Psychiatry Res. 2020, 288, 112954. [CrossRef] [PubMed]
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